Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

51.45
+1.583.17%
Volume:5.22M
Turnover:272.60M
Market Cap:20.32B
PE:-7.09
High:54.02
Open:48.68
Low:48.68
Close:49.87
52wk High:55.20
52wk Low:22.28
Shares:394.94M
Float Shares:363.29M
Volume Ratio:1.81
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.2600
EPS(LYR):-7.2600
ROE:-28.87%
ROA:-14.51%
PB:2.35
PE(LYR):-7.09

Loading ...

Moderately bullish activity in Moderna with shares up 5.92%

TIPRANKS
·
47 mins ago

Early notable gainers among liquid option names on February 23rd

TIPRANKS
·
Yesterday

Moderna Shares Hit One-Month High, Last up 7.5%

THOMSON REUTERS
·
Yesterday

Stock Track | Moderna Soars 5.05% Intraday After Piper Sandler Raises Price Target to $69

Stock Track
·
Yesterday

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO

Reuters
·
Yesterday

Moderna price target raised to $69 from $63 at Piper Sandler

TIPRANKS
·
Yesterday

Is Moderna (MRNA) Pricing Reflect Its mRNA Pipeline Potential After 62% Year To Date Rally

Simply Wall St.
·
Yesterday

BREAKINGVIEWS-The Week in Breakingviews: When activists attack

Reuters
·
Yesterday

Moderna Faces Default Risk as Ares Capital–Led Lenders Gain Power to Accelerate Debt and Seize Collateral

TIPRANKS
·
Feb 22

Weekly Winners | Omnicom Soars 21%; Moderna Surges 18%; Garmin Jumps 16%; Norwegian Cruise Gains 13%

Tiger Newspress
·
Feb 22

Bridgewater Associates' 4Q Buying and Selling -- Barron's

Dow Jones
·
Feb 21

Moderna posts FY 2025 net product sales of USD 1.82 billion (-42%)

Reuters
·
Feb 21

Mixed options sentiment in Moderna with shares down 0.31%

TIPRANKS
·
Feb 21

Moderna and Merck Advance mRNA Cancer Vaccine Trial in First-Line Lung Cancer: What Investors Should Watch

TIPRANKS
·
Feb 21

BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent

MT Newswires Live
·
Feb 20

Overnight Market Update: US Stocks Decline, Oil and Gold Advance, Trump Issues Iran Ultimatum, UK's Former Prince Andrew Released

Deep News
·
Feb 20

Stock Track | Moderna Soars 5.06% Intraday as FDA Reverses Course on Flu Vaccine Review

Stock Track
·
Feb 20

BioNTech Sues Moderna for U.S. Patent Infringement Over Covid Vaccine Mnexspike - U.S. Court Filing

THOMSON REUTERS
·
Feb 20

Moderna to Present at TD Cowen and Barclays Global Healthcare Conferences

Reuters
·
Feb 19

Markets Are in the AI Doldrums. Why Trump's Iran Posturing Could Change That. -- Barrons.com

Dow Jones
·
Feb 19